The Center for Vascular Biotherapeutics is focused on commercializing medical strategies and devices that target blood vessel formation for the treatment of cancer and obstructive vascular diseases such as atherosclerosis. This Center capitalizes on a robust scientific program aimed at deciphering the molecular blueprint for vessel regeneration using human genetics and transgenic mice technologies; these technologies were pioneered at the University of Utah. The "Functional Vascular Genetics" program established at the University of Utah is identifying genes that are essential for vascular development.

Vascular Biotherapeutics 01-02
Vascular Biotherapeutics 02-03

Highlights

• Negotiations for a
  licensee are in progress and we have designed and tested
  a first generation elastin sheath-stent and showed it to be
  effective in preventing restenosis in a porcine model.

Spin Out Companies

• Hydra Biosciences
• Navigen

Benefiting Companies

Center's University Website and Contact Information